Repeated PCP administration induced robust deficits in 5C-CPT performance.
Pre-treatment with dopamine D1 receptor partial agonist, SKF 38393, partially attenuated PCP-induced deficits.
Augmenting dopamine D1 receptors improved PCP-induced deficits by reducing inappropriate responding.